VC
REGN icon

Veracity Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Veracity Capital’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.46M Buy
5,556
+3
+0.1% +$2.04K 0.94% 16
2026
Q1 		$4.29M Sell
5,553
-73
-1% -$55.9K 1.53% 9
2025
Q4 		$4.34M Buy
5,626
+4
+0.1% +$2.72K 1.28% 11
2025
Q3 		$3.16M Buy
5,622
+25
+0.4% +$14.1K 1.01% 10
2025
Q2 		$2.94M Sell
5,597
-4
-0.1% -$2.23K 1.01% 11
2025
Q1 		$3.55M Sell
5,601
-13
-0.2% -$8.94K 1.38% 8
2024
Q4 		$4M Sell
5,614
-58
-1% -$48.7K 1.44% 9
2024
Q3 		$5.96M Sell
5,672
-140
-2% -$156K 2.26% 7
2024
Q2 		$6.11M Sell
5,812
-310
-5% -$301K 2.54% 6
2024
Q1 		$5.89M Sell
6,122
-241
-4% -$229K 2.29% 7
2023
Q4 		$5.59M Sell
6,363
-104
-2% -$85.6K 2.24% 7
2023
Q3 		$5.32M Sell
6,467
-51
-0.8% -$40.1K 2.47% 5
2023
Q2 		$4.68M Buy
6,518
+17
+0.3% +$13.1K 1.99% 7
2023
Q1 		$5.34M Sell
6,501
-293
-4% -$221K 2.47% 7
2022
Q4 		$4.9M Sell
6,794
-145
-2% -$107K 2.35% 5
2022
Q3 		$4.78M Buy
6,939
+2
+0% +$1.26K 2.6% 6
2022
Q2 		$4.1M Sell
6,937
-110
-2% -$71.5K 2.18% 7
2022
Q1 		$4.92M Sell
7,047
-221
-3% -$140K 2.04% 7
2021
Q4 		$4.59M Buy
7,268
+37
+0.5% +$22.7K 1.84% 10
2021
Q3 		$4.38M Sell
7,231
-530
-7% -$329K 1.88% 8
2021
Q2 		$4.33M Sell
7,761
-124
-2% -$62.8K 1.01% 19
2021
Q1 		$3.73M Sell
7,885
-703
-8% -$342K 1.71% 9
2020
Q4 		$4.15M Buy
8,588
+396
+5% +$214K 2.15% 7
2020
Q3 		$4.59M Buy
8,192
+161
+2% +$97.6K 2.57% 4
2020
Q2 		$5.01M Sell
8,031
-8,205
-51% -$4.66M 2.89% 6
2020
Q1 		$7.93M Sell
16,236
-1,086
-6% -$448K 2.29% 12
2019
Q4 		$6.5M Buy
+17,322
New +$5.83M 1.68% 11

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Veracity Capital's REGN Position: Q2 2026 in Review

Veracity Capital increased its Regeneron Pharmaceuticals (REGN) stake by 0.05% in Q2 2026, buying an estimated $2.04K and bringing the position to 5,556 shares worth $3.46M. The position accounts for 0.94% of the portfolio, ranked #16.

Veracity Capital first reported a position in REGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $7.93M in Q1 2020. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Veracity Capital held 5,556 shares of Regeneron Pharmaceuticals worth $3.46M as of Q2 2026.
  • Veracity Capital bought 3 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.04K.
  • Regeneron Pharmaceuticals made up 0.94% of Veracity Capital's portfolio in Q2 2026, its #16 holding.
  • Veracity Capital first reported a position in Regeneron Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
  • Veracity Capital's Regeneron Pharmaceuticals position peaked at $7.93M in Q1 2020.
  • 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Veracity Capital's 13F filing for Q2 2026, filed 13 Jul 2026.